BRIEF-Momenta and CSL announce deal By: Reuters: Company News January 05, 2017 at 16:12 PM EST * Momenta and CSL announce collaboration and license agreement to develop fc multimer programs, including m230, a selective immunomodulator of fc receptors Read More >> Related Stocks: Carlisle Companies Inc Momenta Pharma